Viewing Study NCT02155634

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-03-01 @ 10:10 AM
Study NCT ID: NCT02155634
Status: WITHDRAWN
Last Update Posted: 2018-04-10
First Post: 2014-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Neoplasms View
None Plasma Cells View
None Paraproteinemias View
None Blood Protein Disorders View
None Hematologic Diseases View
None Therapeutic Uses View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Newly Diagnosed Multiple Myeloma View
None Multiple Myeloma View
None Lenalidomide View
None Revlimid View
None Phase III View
None Phase IIIb View
None Plasma Cell Dyscrasia View